Pioglitazone
Product Images NDC 71335-1385

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 71335-1385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical structure of pioglitazone hydrochloride showing its molecular arrangement, including a thiazolidinedione ring and a pyridine group linked by an ether bond.*

FDA Label Image

Figure 1 (Image 2)

A line graph showing mean values over 26 weeks for four groups: placebo, 15 mg, 30 mg, and 45 mg doses. The x-axis represents weeks (0 to 26), and the y-axis represents the mean. The placebo group shows a generally positive trend, while the dose groups show negative trends over time, with the 45 mg group decreasing most sharply.*

FDA Label Image

Label (Lbl713351385)

Pioglitazone 45mg Tablet label from Bryant Ranch Prepack, showing comparison to Actos 45mg Tablet by Teva Pharmaceuticals. Label includes storage instructions (20-25°C), a barcode, lot number, Rx only designation, and a quantity of 30 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.